Latest market price
26.61
-0.94-3.41%
NGNEQT25Neurogene Inc.·NASDAQ
26.61-3.41%

Latest SEC Filings

Form category
DescriptionFilingDocument
Oct 07, 2026SC 13GBeneficial ownership statement (passive)
Oct 06, 2026SC 13GBeneficial ownership statement (passive)
Oct 02, 20264Statement of changes in beneficial ownership
Aug 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 14, 2026SC 13GBeneficial ownership statement (passive)
Aug 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 11, 20268-KCurrent report
Aug 11, 202610-QQuarterly report
Jul 07, 20264Statement of changes in beneficial ownership
Jul 02, 20264Statement of changes in beneficial ownership
Jul 02, 20268-KCurrent report
Jul 02, 2026424B5Prospectus
Jun 30, 2026424B5Prospectus
Jun 29, 20268-KCurrent report
Jun 16, 20263/AInitial statement of beneficial ownership (amended)
Jun 16, 20264/AStatement of changes in beneficial ownership (amended)
Jun 16, 20264/AStatement of changes in beneficial ownership (amended)
Jun 16, 20264/AStatement of changes in beneficial ownership (amended)
Jun 08, 20268-KCurrent report
Jun 04, 20268-KCurrent report
May 12, 20268-KCurrent report
May 12, 202610-QQuarterly report
May 08, 20264Statement of changes in beneficial ownership
May 07, 20264Statement of changes in beneficial ownership
Apr 20, 20263Initial statement of beneficial ownership